| Ytd | 45.37% | |
| 1y | 57.14% |
| Open | 34.58 | Prev Close | 34.64 | Low | 34.58 | High | 35.16 | Mkt Cap | 1.72B |
| Vol | 139.71K | Avg Vol | 1.12M | EPS | -0.21 | P/E | -166.31 | Forward P/E | 105.03 |
| Beta | 1.93 | Short Ratio | 2.70 | Inst. Own | 104.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 28.70 | 200-d Avg | 24.57 | 1yr Est | 31.13 |
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zack
Total revenue of $28.5 million, up 21% over Q2 2025 GAAP gross margin of 64% and non-GAAP adjusted g
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
RGEN's $1.5 billion BioLife acquisition aims to expand its cell therapy capabilities, adding biopres
Repligen NASDAQ: RGEN said it has signed a definitive agreement to acquire BioLife Solutions in a tr
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (
NEW YORK, July 22, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Ass
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price
MILWAUKEE, July 22, 2026 /PRNewswire/ -- Ademi LLP is investigating BioLife (NASDAQ: BLFS) for possi
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc.
Life sciences company Repligen Corporation (NASDAQ:RGEN) on Wednesday agreed to acquire cell process
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale
Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at
Fast-tracks Repligen's leadership and customer solution offering in high-growth cell therapy market
On May 28, 2026, BioLife Solutions Inc (BLFS) shares rose 3.1% to a current price of $25.25. This mo
BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcript
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zack
Total revenue of $27.5 million, up 25% over Q1 2025 GAAP gross margin and non-GAAP adjusted gross ma
The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026,
BioLife Solutions, Inc. (NASDAQ: BLFS - Get Free Report) shares crossed below its 200-day moving ave
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea
Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly
Gainers
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wedn
Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Tuesday, 242 companies hit new 52-week lows.
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo
During Tuesday's trading, 505 companies set new 52-week lows.
On Thursday, 147 companies achieved new lows for the year.
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46
Gainers
Before 10 a.m. ET on Wednesday, 124 companies hit new 52-week highs.
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report
This morning 113 companies reached new 52-week highs.
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report
Wednesday morning saw 335 companies set new 52-week highs.